NCT00470262View on ClinicalTrials.gov

Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

June 30, 2014

Conditions
Metabolic Syndrome XPrediabetic State
Interventions
DRUG

Fenofibrate 145mg PO QD

Subjects will be randomized to either fenofibrates or combination of both fenofibrate and pioglitazone

DRUG

Pioglitazone 45 mg PO QD

Subjects will be randomized to either fenofibrate 145 mg PO QD or a combination of both fenofibrate 145 mg PO QD and pioglitazone 45 mg PO QD

Trial Locations (1)

80220

VA Eastern Colorado Health Care System, Denver, Denver

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00470262 - Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation | Biotech Hunter | Biotech Hunter